நம்பகத்தன்மை வாழ்க்கை அறிவியல் பிரைவேட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நம்பகத்தன்மை வாழ்க்கை அறிவியல் பிரைவேட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நம்பகத்தன்மை வாழ்க்கை அறிவியல் பிரைவேட் Today - Breaking & Trending Today

Global Filgrastim Biosimilars Market Report 2020: COVID-19 Impacts, Growth and Changes


Share this article
Share this article
ResearchAndMarkets.com s offering.
Major players in the filgrastim biosimilars market are Cadila Pharmaceuticals, Dr. Reddy s Laboratories, Intas Biopharmaceuticals, Sandoz, Amgen Inc., Dr. Reddy s Laboratories Ltd, Intas Pharmaceuticals, Emcure Pharmaceuticals Ltd., Biocon and Aryogen Biopharma.
The global filgrastim biosimilars market is expected to decline from $511.15 million in 2019 to $445.04 million in 2020 at a compound annual growth rate (CAGR) of -12.93%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $751.96 billion in 2023 at a CAGR of 19.11%. ....

Adello Biologics , Kashiv Biosciences , Aryogen Biopharma , Kashiv Pharma , Laura Wood , Reliance Life Sciences Pvt , Biosimilar Awareness Initiative , Biosimilar Medicines Association , Custom Research , Roche Ltd , Abbott Laboratories Inc , Teva Pharmaceuticals Industries , Office Hours Call , Emcure Pharmaceuticals Ltd , Drug Administration , Claris Lifesciences , E St Office Hours Call , Amgen Inc , Intas Pharmaceuticals , European Medicines Agency , Reddy Laboratories Ltd , Cadila Pharmaceuticals , Biosimilars Global Market Report , Intas Biopharmaceuticals , Laboratories Ltd , Biosimilar Action Plan ,